25-27 September 2025
Registration and accommodation bookings opening soon!
The European Academy of Paediatrics (EAP) invites you to an exceptional opportunity to accelerate your leadership journey. Join peers and mentors from across Europe for three dynamic days of interactive learning, skill-building, and professional networking in one of Germany’s most vibrant cities.
Designed for emerging paediatric leaders and young professionals in medical advocacy and public relations, the EAP Leadership Academy will help you develop essential leadership competencies and master the art of influencing change within the healthcare landscape.
Places are strictly limited to 30 participaants to ensure an intensive and personalised experience.
The EAP Leadership Academy 2025 is proudly supported by:
Increasing the positive impact of nutrition.
Transforming the practice of medicine through breakthrough science.
🕢 Thursday throughout the day
🕢 19:00 onwards
Engage in a unique, interactive icebreaker during dinner!
Prof. Suzanne Suggs & Prof. Berthold Koletzko
🎥 Media communication – Dr. Daniel Saraga
📱 Social media engagement - by Young EAP Country Representatives.
🎯 Advocacy introduction - exciting presenter to be announced soon!
🩺 Patient-provider communication – Prof. Suzanne Suggs
⚖️ Regulatory science & paediatrics – watch this space, presenter to be announced soon!
– Dr. Daniel Saraga
– Watch this space!
– Prof. Suzanne Suggs
– Dr. Daniel Saraga
– Watch this space!
– Prof. Suzanne Suggs
– Dr. Daniel Saraga
– Watch this space!
– Prof. Suzanne Suggs
Enjoy a 3-course dinner Rooftop, Rathuasbar, Melia Hotel.
🎥 Media: Mock interviews & media exercises
📱 Social Media & Patient Communication: Showcase of strategies
🎯 Advocacy: Role-play panel discussions & stakeholder messaging
🎯 Key elements for effective advocacy
🌍 Paediatric advocacy at EU/international level – Prof. Berthold Koletzko
🏢 Lessons from corporate advocacy
💡 Panel insights: Berthold Koletzko
The EAP Leadership Academy faculty includes paediatric experts, trailblazing advocates, and experienced leaders who have shaped the future of child health.
They’re here to challenge, guide, and inspire you to become the next voice of paediatrics in Europe.
Leadership Academy Programme Director
Full Professor of Social Marketing, USI, Switzerland Prof. Suggs leads the BeCHANGE research group at the Università della Svizzera italiana and is Vice-President of the Swiss School of Public Health. She has served as co-chair of the Swiss National COVID-19 Science Task Force and is an expert in health communication, vaccination acceptance, and behavioural health strategies. Prof. Suggs advises governments and institutions on science communication and health policy, and teaches internationally on health communication and social marketing.
Leadership Academy Programme Director
President, EAP & Chair, EAP Leadership Academy
Prof. Koletzko is the Else Kröner-Senior Professor of Paediatrics at LMU Munich and Head of the Division of Metabolic and Nutritional Medicine at Dr. von Hauner Children's Hospital. An internationally recognised expert in paediatric nutrition and metabolism, he has authored over 1,200 scientific articles and holds leadership roles in several global health organisations. He is also the founder and chair of the Child Health Foundation, dedicated to promoting evidence-based child health initiatives.
President, EAP & Chair, EAP Leadership Academy
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.